Close
  Indian J Med Microbiol
 

Figure 3: Maintenance of improvement after 52 weeks of therapy. Photographs of patients under study before initiation of secukinumab (a-d). Maintenance of remission at 52 weeks (posttreatment photograph) (e-h)

Figure 3: Maintenance of improvement after 52 weeks of therapy. Photographs of patients under study before initiation of secukinumab (a-d). Maintenance of remission at 52 weeks (posttreatment photograph) (e-h)